EcoDrugPlus

Ptk6 Protein Tyrosine Kinase 6a

Ensembl ID : ENSDARG00000017947
Gene Symbol: PTK6A
4 Cross references
109 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSDARG00000059956
Gene Symbol: PTK6B
23 Enzyme and pathways 5 Cross references
160 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSDARG00000100020
Gene Symbol: PIM1
5 Cross references
250 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSDARG00000055129
Gene Symbol: PIM3
5 Cross references
174 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSDARG00000102328
Gene Symbol: RAF1A
3 Cross references
206 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSDARG00000096415
Gene Symbol: RAF1A
19 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase B

Ensembl ID : ENSDARG00000059406
Gene Symbol: RAF1B
19 Enzyme and pathways 5 Cross references
156 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSDARG00000058993
Gene Symbol: ROCK1
24 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Sem1 26s Proteasome Complex Subunit

Ensembl ID : ENSDARG00000027899
Gene Symbol: SEM1
5 Cross references
156 Possible Orthologues:

Tek Tyrosine Kinase, Endothelial

Ensembl ID : ENSDARG00000028663
Gene Symbol: TEK
10 Enzyme and pathways 5 Cross references
166 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSDARG00000058221
Gene Symbol: UGCG
4 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSDARG00000093864
Gene Symbol: WEE1
16 Enzyme and pathways 5 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).